首页> 外文期刊>BMC Infectious Diseases >Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania
【24h】

Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania

机译:坦桑尼亚达累斯萨拉姆患者临床感染患者对艾滋病毒感染患者的Isoniazid预防治疗的可接受性和粘附性

获取原文
           

摘要

Proper adherence to isoniazid preventive therapy (IPT) may depend upon the results of tuberculosis (TB) screening test and patients’ understanding of their risk of developing active TB. We conducted a study to assess the acceptability, adherence and completion profile of IPT among HIV-infected patients who were clinically screened for latent TB Infection (LTBI). A multicenter observational study was conducted in Dar es Salaam, Tanzania between February 2012 and March 2014. HIV-infected patients 10?years or older were clinically screened using a validated symptom-based screening tool to rule out active TB. Patients found to have no symptoms in the screening tool were given 300?mg of isoniazid (INH) daily for 6?months. Patients were followed up monthly at the National and Municipal hospital HIV clinics for INH refill and assessment of treatment adherence. Adherence was defined as consumption of 90?% or more of the monthly prescription of INH. All 1303 invited patients agreed to participate in the study. Of 1303 invited HIV-infected patients, 1283 (98.5?%) were recruited into the study. Twenty eight (2.2?%) did not complete treatment. Those who did not complete the treatment were exclusively adults aged 18?years or older, p?=?0.302. The overall mean (±SD) adherence was 98.9?% (±2.9). Adherence level among children aged <18?years (92.2?%) was significantly lower than adherence level among patients aged 18–29 years (98.3?%), 30–49 years (98.8?%) and?≥?50?years (98.5), p-value?=?0.011. Sex, occupation, socio-economic status, duration of HIV infection, being on antiretroviral drugs (ARV) and duration of ARV use were not associated with adherence. IPT is highly accepted by HIV infected patients. Patients demonstrated high level of adherence to IPT. The level of adherence among children was slightly lower than that among adults. IPT non-completers were exclusively adults. Children might need adult supervision in taking IPT.
机译:适当的依从性对等尼噻虫预防治疗(IPT)可能取决于结核病(TB)筛查试验和患者对其发育活性结核病风险的理解的结果。我们进行了一项研究,评估IPT在临床上筛选的艾滋病毒感染患者中的可接受性,遵守和完成概况,用于临床筛查潜伏的TB感染(LTBI)。 2012年2月至2014年3月坦桑尼亚的达累斯萨拉姆在达累斯萨拉姆进行了多中心观察研究。艾滋病毒感染患者10?使用验证的基于症状的筛选工具临床筛选到临床筛选,以排除活跃的TB。在筛查工具中发现没有症状的患者每天给予300μm,每天6个月,6?数月。患者在全国和市医院HIV诊所进行一次,以inh infill和评估治疗依从性。依从性被定义为每月处方的90%或更多的消耗量。所有1303人邀请患者同意参加该研究。 1303名邀请艾滋病毒感染患者,1283名(98.5〜%)被招募到该研究中。二十八(2.2?%)没有完全治疗。那些没有完成治疗的人都是18岁的成年人(年龄),p?= 0.302。总体平均值(±SD)粘附性为98.9?%(±2.9)。年龄<18岁的儿童(92.2?%)的粘附水平显着低于18-29岁的患者(98.3?%),30-49岁(98.8?%)和?≥?50?年( 98.5),p值?=?0.011。性,占领,社会经济地位,艾滋病毒感染持续时间,在抗逆转录病毒药物(ARV)和ARV使用持续时间与依从性无关。 IPT受艾滋病毒感染患者的高度认可。患者表现出高水平的粘附。儿童的粘附程度略低于成年人中的依赖程度。 IPT非完善者都是成年人。孩子们可能需要成人监督服用IPT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号